Insider Trading Summary for Recursion Pharmaceuticals, Inc. (RXRX): Year

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
03-Apr-24 5:42 PM View:	01-Apr-24 Grant 0	Burrell Terry-Ann Director		Recursion Pharmaceuticals, Inc. - RXRX	(65%) 159.24K to 56.31K	0	0	--	--	Show Txns Hide Txns

03-Apr-24 5:43 PM View:	01-Apr-24 Grant 0	Chavez R Martin Phd Director		Recursion Pharmaceuticals, Inc. - RXRX	56% 38.41K to 60.08K	0	0	--	--	Show Txns Hide Txns

03-Apr-24 5:43 PM View:	01-Apr-24 Grant 0	Dar Zavain Director		Recursion Pharmaceuticals, Inc. - RXRX	55% 57.57K to 89.06K	0	0	--	--	Show Txns Hide Txns

21-Jun-23 5:20 PM View:	16-Jun-23 Grant 0	Hershberg Robert Director		Recursion Pharmaceuticals, Inc. - RXRX	48% 26.01K to 38.62K	0	0	--	--	Show Txns Hide Txns

29-Apr-24 6:41 PM View:	25-Apr-24 Planned Option Sale ($23.02K)	Larson Tina Marriott President and COO		Recursion Pharmaceuticals, Inc. - RXRX	28% 424.16K to 543.23K	0	0	--	--	Show Txns Hide Txns

03-Apr-24 5:43 PM View:	01-Apr-24 Grant 0	Li Dean Y Director		Recursion Pharmaceuticals, Inc. - RXRX	(17%) 3.81M to 3.17M	0	($396.21K) (1%)	--	$13.66	Show Txns Hide Txns

18-Apr-24 5:12 PM View:	17-Apr-24 Planned Option Sale ($175.35K)	Secora Michael Chief Financial Officer		Recursion Pharmaceuticals, Inc. - RXRX	55% 792.91K to 1.23M	0	0	--	--	Show Txns Hide Txns

06-Jul-23 6:04 PM View:	03-Jul-23 Grant 0	Bogue Zachary Director 10% Owner		Recursion Pharmaceuticals, Inc. - RXRX	0% 13.63M to 13.63M	0	0	--	--	Show Txns Hide Txns

02-May-24 5:41 PM View:	30-Apr-24 Sale (Planned) ($90.96K)	Borgeson Blake Director		Recursion Pharmaceuticals, Inc. - RXRX	(4%) 7.56M to 7.22M	0	($273.20K)	--	$13.62	Show Txns Hide Txns

03-May-24 6:24 PM View:	02-May-24 Sale (Planned) ($423.50K)	Gibson Christopher Chief Executive Officer Director		Recursion Pharmaceuticals, Inc. - RXRX	(11%) 941.56K to 834.82K	0	0	--	--	Show Txns Hide Txns

18-Jan-24 6:39 PM View:	16-Jan-24 Planned Option Sale ($196.74K)	Virani Shafique Chief Business Officer		Recursion Pharmaceuticals, Inc. - RXRX	(27%) 186.82K to 136.75K	0	0	--	--	Show Txns Hide Txns

13-Feb-24 7:03 PM View:	09-Feb-24 Payment of Exercise ($19.09K)	Mauro David J Chief Medical Officer		Recursion Pharmaceuticals, Inc. - RXRX	100% 0 to 244.63K	0	0	--	--	Show Txns Hide Txns

Buy:	0	--
Sell:	($669.42K)	$13.62 - $13.66

Recursion Pharmaceuticals, Inc. (RXRX)

Last Year

16-May-23 -- 15-May-24

Company Sentiment

Other

Other

Two Year Chart

16-May-22 -- 15-May-24

Price ($)

Sentiment

Buy & Sell Volume ($)

Recent Insider Trades